If your goal is support (energy, adherence, routine) inside a broader program, lipotropic injections may be a supportive add-on but they should not be positioned as the main driver of weight loss
Christensen, R., Kristensen, P
A large study by Ohno and colleagues, published in Nature in 2020, found that the risk of developing RA rises with every roughly 5 kg of weight gain or every inch added to your waistline
This meant GLP-1 would need to be given in high doses if it was to have any therapeutic potential
Additionally, GLP-1 (50 nM) protected against synaptic dysfunction in the rat hippocampus induced by injection of lipopolysaccharide (LPS) (Iwai et al., 2014)
These products are not FDA-approved, have not been reviewed by FDA for safety and effectiveness, and FDA cautions they can lead to serious and potentially life-threatening adverse health consequences including infections and sepsis. Knock-off versions of semaglutide pose significant threats to peoples health and safety, a Novo Nordisk spokesperson said in an email to Healio | Endocrine Today
